The coronavirus vaccines are safer than aspirin or Tylenol
Since the release of the coronavirus vaccines, there has been a lot of overheated coverage of their potential side effects (most recently from podcaster Joe Rogan).
In truth, the risk of the coronavirus vaccines is microscopic. A good way to understand this is by comparing them to common over-the-counter painkillers.
Take aspirin. As Dr. Nathan Grills from the University of Melbourne points out, this drug has all kinds of rare but bad side effects — certain kinds of heart failure, strokes, intestinal bleeding, and on and on. One study estimated that for 50-year-old men, 325 milligrams of aspirin daily ran a fatality risk of 10.4 per 100,000 person-years.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Acetaminophen (commonly known as Tylenol) is even worse. This drug is both less helpful than aspirin and much easier to overdose on than people tend to think. Take just a bit more than the maximum recommended dose, and severe complications follow. It's also a brutal overdose mechanism — if it isn't caught in time, then there is basically no way to prevent a slow and excruciating death from liver failure. A 2006 study estimated that acetaminophen overdoses over one year were responsible for 56,000 trips to the emergency room, 26,000 hospitalizations, and 458 deaths — 100 of them accidental. What's more, the drug may have additional rare side effects like hormone disruption or asthma.
Let's compare to the coronavirus vaccines. The most serious complications reported after many billions of doses administered are unusual blood clots from AstraZeneca and Johnson & Johnson vaccines (made with traditional technology) and heart swelling from the Pfizer/Moderna mRNA shots. The clotting risk is so tiny it might not exist at all — some studies have found a few dozen cases of clotting and a handful of deaths out of hundreds of millions of AstraZeneca/J&J doses administered, but the European Medical Agency concluded AstraZeneca at least does not actually increase clotting risk. There does appear to be a risk of heart swelling with the mRNA vaccines, particularly for young men, but it's extremely small — a 2.13 in 100,000 risk according to one study, or a 23 in 2.8 million risk in another. Moreover, in the large majority of cases, the swelling was mild and recovery was quick.
In short, the coronavirus vaccines have a risk of serious side effects that is something like an order of magnitude less than the risk of dying from taking aspirin regularly (as half of adults over 45 do), and have virtually no risk of death.
Anyway, of course it would be wrong to ban aspirin because it does have many benefits: improving heart health in some populations, reducing the risk of some cancers, and so on (though personally, I would not allow acetaminophen to be sold over the counter anymore). It's simply that the benefits of aspirin come at a small risk — so small that most nations don't even bother requiring a doctor's note to get it.
The coronavirus vaccines are both much, much more beneficial than aspirin, and much, much less risky. There is simply no reason to fret about them.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Ryan Cooper is a national correspondent at TheWeek.com. His work has appeared in the Washington Monthly, The New Republic, and the Washington Post.
-
The Onion is having a very ironic laugh with Infowars
The Explainer The satirical newspaper is purchasing the controversial website out of bankruptcy
By Justin Klawans, The Week US Published
-
'Rahmbo, back from Japan, will be looking for a job? Really?'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
What's next for electric vehicles under Trump?
Today's Big Question And what does that mean for Tesla's Elon Musk?
By Joel Mathis, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published